Cite Filings / CRL / 0001100682-25-000014
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
8-K

Current Report

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. · Filed 2025-02-21 · Acc 0001100682-25-000014

Other events

  • Item 8.01 Other events

From the SEC's structured data for this filing

Documents 1

  • 8-K Current Report , crl-20250220.htm

Around this filing

  • 2025-05-07 8-K Material agreement · Executive or director change · Regulation FD disclosure
  • 2025-02-21 4 Chairman, President and CEO bought 6,075 shares at $165.01 ($1,002,436)
  • 2025-02-21 4 Corporate Executive VP & COO bought 1,514 shares at $164.63 ($249,250)
  • 2025-02-21 4 EVP, Corp Strategy & Develop sold 4,400 shares at $162.50 ($715,000)
  • 2025-02-21 8-K Other events
  • 2025-02-20 144 Sale of Securities
  • 2025-02-19 8-K Results of operations

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
  • SEC Structured Data (opens in new tab)
Loading crl-20250220.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…